Skip to content
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
Donate
HR Login
MSF SA Login
›
Category: MSF in news
Pharma company Viiv's attempt to secure patents for key HIV drugs dolutegravir and cabotegravir opposed in India
Read More
Pharma Company Viiv’s Attempt to Secure Patents for Key HIV Drugs Dolutegravir and Cabotegravir Opposed in India
Read More
Three killed in airstrikes on Syrian hospital
Read More
40,000 die from leishmaniasis every year, but it is still neglected: Study
Read More
Syria Air strike hits MSF-supported hospital, 3 dead
Read More
Antibiotics do not help in treatment of malnourished children
Read More
Bombing medical facilities: Is this the new normal?
Read More
Ethics at its Core
Read More
India's Battle Against HIV Yields Uneven Gains
Read More
In photos: Traumatic recoveries for Syria's war-wounded civilians
Read More